S.1695 - Biologics Price Competition and Innovation Act of 2007

A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. view all titles (2)

Close

All Bill Titles

  • Short: Biologics Price Competition and Innovation Act of 2007 as introduced.
  • Official: A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

06/27/07
Senate Committee Passes Follow-On Biologics Bill

The Biologics Price Competition and Innovation Act, S. 1695, allows the FDA to use its scientific discretion in approving products that are biosimilar to ...

Source: FDA news (subscription), VA
Add to My Political Notebook Save to Notebook Rate
06/26/07
Panel OKs Bill to Spur Generic Versions of Biotech Drugs

... amendments from both sides, preserving what they described as a delicate compromise on the legislation ( S 1695 ), which was approved by voice vote. ...

Source: Congressional Quarterly, DC
Add to My Political Notebook Save to Notebook Rate
Information made available by Daily Life

Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC
Save to Notebook Make A Bill Widget

Recent OC Blog Articles

OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.